Bide Pharmatech Co., Ltd. (SHA:688073)

China flag China · Delayed Price · Currency is CNY
44.31
+2.87 (6.93%)
At close: May 29, 2025, 2:57 PM CST
35.22%
Market Cap 3.84B
Revenue (ttm) 1.14B
Net Income (ttm) 122.04M
Shares Out 87.68M
EPS (ttm) 1.37
PE Ratio 31.95
Forward PE 27.37
Dividend 0.90 (2.06%)
Ex-Dividend Date n/a
Volume 2,311,915
Average Volume 1,208,698
Open 41.15
Previous Close 41.44
Day's Range 41.15 - 45.00
52-Week Range 28.50 - 61.66
Beta 0.52
RSI 55.48
Earnings Date Aug 6, 2025

About Bide Pharmatech

Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company’s products are used in life sciences, organic chemistry, materials science, analytical chemistry, and other applications. The company was incorporated in 2007 and is headquartered in Shanghai, China. [Read more]

Sector Healthcare
Founded 2007
Employees 738
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688073
Full Company Profile

Financial Performance

In 2024, Bide Pharmatech's revenue was 1.10 billion, an increase of 0.93% compared to the previous year's 1.09 billion. Earnings were 117.43 million, an increase of 7.17%.

Financial Statements

News

There is no news available yet.